PSTX - Poseida Therapeutics appoints Kristin Yarema as CEO
2023-10-09 16:49:24 ET
More on Poseida Therapeutics
- Poseida Therapeutics: Why I Am Still Holding On To The Stock Into 2024 (Rating Downgrade)
- Poseida Therapeutics' Financial And Clinical Milestones Signal Upgrade To 'Strong Buy'
- Poseida jumps on $50M investment from Astellas
For further details see:
Poseida Therapeutics appoints Kristin Yarema as CEO